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Background: Endothelium plays an important role in mediating the function of
transplanted organs. The widely used University of Wisconsin solution impairs the
endothelium-derived hyperpolarizing factor–mediated relaxation in coronary arter-
ies, but little is known about effects of lung preservation on endothelium-derived
hyperpolarizing factor–mediated endothelial function. This study examined the
effect of organ preservation solutions on the endothelium-derived hyperpolarizing
factor–mediated relaxation in the pulmonary microarteries (diameter 200 to 450
m).
Methods: Two segments (1 as control) from the same microartery were allocated in
2 chambers of a myograph. After incubation with hyperkalemia (potassium 115
mmol/L), University of Wisconsin, or Euro-Collins solution (at 4°C for 4 hours), the
endothelium-derived hyperpolarizing factor–mediated relaxation was induced by
bradykinin (10 to 6.5 log M, n  8) or calcium ionophore (A23187, 9 to 5.5
log M, n  7) in U46619 (7.5 log M) precontracted rings in the presence of
indomethacin (7 mol/L), NG-nitro-L-arginine (300 mol/L), and oxyhemoglobin
(20 mol/L).
Results: Exposure to hyperkalemia and storage with Euro-Collins or University of
Wisconsin solution significantly decreased the relaxation to bradykinin (51.9 
8.4% vs 60.3  6.1%, P  .02 or 49.3  7.3% vs 65.2  3.5%, P  .04) or A23187
(12.5  0.02% vs 33.8  0.07%, P  .02 or 13.2  0.03% vs 31.0  0.05%, P 
.03%).
Conclusions: Endothelium-derived hyperpolarizing factor plays an important role in
porcine pulmonary microarteries, and the endothelium-derived hyperpolarizing fac-
tor–mediated relaxation is impaired when the lung is preserved with University of
Wisconsin or Euro-Collins solution. This impairment may affect the lung function
during the reperfusion period after lung transplantation.
During the preservation period of the donor organ, the vascularendothelium is in direct contact with preservation solutions. Theeffect of organ preservation solutions on the endothelium istherefore an important issue in organ transplantation surgery. Infact, the effect of hyperkalemia, one of the major components inorgan preservation solutions, and the effect of the solutions have
been investigated in several recent studies.1-10 It has been suggested that University
of Wisconsin (UW) solution reduces the endothelium-dependent relaxation or
causes endothelial dysfunction.4,7,8,10
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Endothelium is an important modulator of vascular tone.
Endothelium-dependent relaxation is known to be the effect
of a variety of endothelium-derived relaxing factors
(EDRFs). These are endothelium-derived nitric oxide
(NO),11 prostacyclin (PGI2), and endothelium-derived hy-
perpolarizing factor (EDHF).6-9,12-17 Because of the com-
plexity of the endothelial function, it is necessary to study
the effect of preservation solutions on individual EDRFs to
explore the best method for preservation of the endothe-
lium. Euro-Collins (E-C) or UW solution has been used for
clinical lung transplantation. However, the effect of E-C and
UW on the EDHF-mediated endothelial function in the
pulmonary artery has not been reported.
Because potassium (K) at high concentrations (hyper-
kalemia) is a key component in organ preservation solutions
for transplantation or in cardioplegic solutions, we have
performed a series of experiments to examine the effect of
hyperkalemia on endothelial function. Our previous studies
have demonstrated that when the production of NO and
PGI2 is inhibited, the residual relaxation (mediated by
EDHF) is significantly reduced by exposure to hyperkale-
mia (K concentration of 20 to 50 mmol/L).3,6,9 The mech-
anism of the impaired EDHF-mediated relaxation after ex-
posure to hyperkalemia is related to the inhibition of K
channels and prolonged depolarization of the smooth mus-
cle membrane potential.6,9
In E-C or UW solution, concentrations of K is as high
as 115 or 125 mmol/L. The extremely high K concentra-
tion in E-C and UW solutions is a major concerns with
regard to endothelial preservation.10 However, the compo-
sition of E-C or UW is complex and the effect of these
organ preservation solutions may therefore be complicated
by their multiple components. In fact, the effect of storage
of the lung with E-C and UW solutions on the EDHF-
mediated relaxation in the pulmonary artery is unknown.
We therefore designed the present study to examine, in
the porcine pulmonary microartery, (1) whether the EDHF-
mediated relaxation exists and (2) the effect of hyperkale-
mia and cold storage with E-C or UW solution, similar to
the clinical setting, on the EDHF-mediated endothelial
function and the contractility of the artery.
Methods
Microarterial Preparation
Fresh porcine lungs collected from a local slaughterhouse were
placed in a container filled with cold Krebs’ solution and imme-
diately transferred to the laboratory. Upon receipt of the lung,
intralobular pulmonary microarteries (usually small branches of
the upper lobe artery, diameter 200 to 450 m) were carefully
dissected and removed under a microscope. The vessels were
cleaned of fat and connective tissue and cut into cylindrical rings
of 2-mm length under a microscope. The Krebs’ solution was
aerated with a gas mixture of 95% O2–5% CO2 at 37°C and had
the following composition (in millimoles per liter): NaCl: 118.4;
KCl: 4.7; MgSO4.7H2O: 1.2; KH2PO4: 1.2; NaHCO3: 25; ()-
glucose: 11.1; and CaCl2.2H2O: 2.5. This gives the following final
molar concentration (in millimoles per liter): 143.4 Na, 5.9 K,
2.5 Ca2, 1.2 Mg2, 128.7 Cl, 25 HCO3, 1.2 SO42, 1.2
H2PO4, and 11.1 glucose. During the above procedure, the en-
dothelium was intentionally preserved by cautiously dissecting and
mounting the rings.
Normalization
After the rings were mounted in a 2-channel myograph (model
500A; J.P. Trading, Aarhus, Denmark), a previously described
method4,6 was used to normalize vascular rings under a condition
simulating the transmural pressure encountered in vivo in the
pulmonary microartery. Briefly, the artery rings were progres-
sively stretched until the passive transmural pressure reached 40
mm Hg. The internal circumference was then set to a normalized
value, estimated to be equivalent to 90% of the circumference at a
passive transmural pressure of 40 mm Hg. The transmural pressure
at this point is about 30 mm Hg. This pressure was maintained
throughout the experiments.
Protocol
After the normalization procedure, the microarterial rings were
equilibrated for at least 20 to 45 minutes.
Precontraction
The vessel was contracted with thromboxane A2 mimetic (U46619,
7.5 log M). This dose was chosen from our pilot experiment in
which the effective concentration causing 50% of the maximal
response (EC50, see “Data Analysis” below) for U46619-induced
contraction was 7.4  0.4 log M, calculated from the concentra-
tion-response curves in porcine pulmonary microarteries (n  8;
taken from 8 porcine lungs). U46619 at 7.5 log M caused a stable
submaximal contraction of all rings.
The following inhibitors were used: cyclooxygenase inhibitor
indomethacin (INDO), 7 mol/L; the nitric oxide (NO) synthesis
inhibitor, NG-nitro-L-arginine (L-NNA), 300 mol/L; and a potent
NO scavenger oxyhemoglobin (HbO), 20 mol/L.
Role of EDHF-Mediated (INDO-, L-NNA-, and HbO-
Resistant) Relaxation in Porcine Pulmonary
Microarteries by Bradykinin or Calcium Ionophore
A23187
With the presence of INDO, L-NNA, and HbO, concentration-
relaxation curves to bradykinin (BK; 10 to 6.5 log M) or A23187
(9 to 5.5 log M) were established when the U46619-induced
contraction reached a plateau. This relaxation is considered to be
related to EDHF because both NO and PGI2 are abolished.12-14
Two rings taken from the same microartery were mounted in
the 2 chambers and equilibrated for 45 minutes. The normalization
procedure was then performed. INDO (7 mol/L), L-NNA (300
mol/L), and HbO (20 mol/L) were then added into 1 chamber
and the other was used as control. After the precontraction with
U46619 (7.5 log M), cumulative concentration-relaxation curves
to BK (n  8) or A23187 (n  7) were established.
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Effect of Hyperkalemia or Preservation Solutions (E-C
or UW) on the EDHF-Mediated Relaxation by BK or
A23187
The effect of hyperkalemia. For group I, 2 rings taken from
the same microartery were mounted in the 2 chambers. After
normalization procedure, 1 ring was incubated with hyperkalemia
(K 115 mmol/L) for 1 hour at 37°C and the other was used as
control (Krebs’ solution). The rings were then repeatedly washed
with Krebs’ solution and incubated with INDO, L-NNA, and HbO.
In the U46619-induced precontraction, cumulative concentration-
relaxation curves to BK (group Ia, n  8) or A23187 (group Ib, n
 7) were established.
In the hyperkalemic solution, K 115 mmol/L was used to
replace the equivalent Na in the Krebs’ solution.
Effect of E-C solution on the EDHF-mediated relaxation.
For group II, 2 rings taken from the same microartery were
mounted in the 2 chambers. One ring was incubated with E-C
solution and the other with Krebs’ as control for 4 hours at 4°C (in
a refrigerator). After storage for 4 hours, both rings were repeat-
edly washed with Krebs’ solution and the normalization procedure
was performed. The rings were incubated with INDO, L-NNA, and
HbO. In the U46619-induced precontraction, cumulative concentra-
tion-relaxation curves to BK (group IIa, n  8) or A23187 (group
IIb, n  7) were established.
Effect of UW solution on the EDHF-mediated relaxation.
For group III, the protocol was the similar to that in group II,
except that the ring was incubated in UW solution instead of E-C
solution.
Effect of UW and E-C solutions on the contractility of the
pulmonary microartery. For group IV, 2 rings taken from the
same microartery were mounted in the 2 chambers. One ring was
incubated with E-C (group IVa) or UW solution (group IVb) and
the other with Krebs’ as control at 4°C (in a refrigerator). After
storage for 4 hours, both rings were repeatedly washed with Krebs’
solution and the normalization procedure was performed. Cumu-
lative concentration-contraction curves to U46619 (10 to6.5 log
M) were then established (n  8).
The compositions of E-C and UW solution are shown in
Table 1.
In all experiments, only 1 concentration-relaxation (contrac-
tion) curve was obtained from each pulmonary ring. A mean
concentration-relaxation curve was calculated from a group of
experiments. During the experiment, the myograph chambers were
continuously bubbled with a gas mixture of 95% O2 and 5% CO2.
Data Analysis
Relaxation was expressed as the percentage decrease in isometric
force induced by U46619. The effective concentration of BK that
caused 50% of maximal relaxation was defined as EC50. The
EC50 was determined from each concentration-relaxation curve by
a logistic, curve-fitting equation: E  MAP/(AP  KP), where E is
response, M is maximal relaxation, A is concentration, K is EC50
concentration, and P is the slope parameter. From this fitted
equation, the mean EC50  SEM was calculated for each group.
TABLE 1. Components of University of Wisconsin (UW) and
Euro-Collins (E-C) solutions
Components UW E-C
Na 29 mmol/L 10 mmol/L
K 125 mmol/L 115 mmol/L
Mg2 5 mmol/L
Cl 15 mmol/L
HCO3
 10 mmol/L
H2PO4
 25 mmol/L 15 mmol/L
HPO4
2 42.5 mmol/L
Pentafraction 50 g/L
Lactobionic acid 35.83 g/L
Raffinose 17.83 g/L
Adenosine 1.34 g/L
Allopurinol 0.136 g/L
Total glutathione 0.922 g/L
Glucose 195 mmol/L
Osmolarity 320 mOsm/kg 375 mOsm/kg
Figure 1. Mean concentration-relaxation (% of contraction by
U46619) curves for bradykinin (BK, n  8) or A23187 (n  7) with or
without indomethacin (INDO, 7 mol/L), NG-nitro-L-arginine
(L-NNA, 300 mol/L), and oxyhemoglobin (HbO, 20 mol/L). Two
artery rings were taken from the same artery and allocated into the
paired groups. Vertical error bars are 1 SEM. *P < .05, paired t test.
Cardiothoracic Transplantation Zou et al
210 The Journal of Thoracic and Cardiovascular Surgery ● July 2003
TX
Statistical Analysis
Data were expressed as mean  SEM and were analyzed with
ANOVA (followed by Scheffe´ F test) or t test when appropriate.
Values of P less than .05 were considered significant.
Drugs
Chemicals used and their sources were as follows: BK, A23187,
L-NNA, Indo, HbO (Sigma Chemical Co, St Louis, Mo), U46619
(Cayman Chemical, Ann Arbor, Mich). L-NNA (dissolved in dis-
tilled water) and INDO (dissolved in ethanol) were stored at 4°C.
The solutions of U46619, HbO, and BK were held frozen until
required. The source of E-C solution (marketed as Euro-Collins
Solution) is Fresenius AG (Homburg, Germany) and of UW so-
lution (marketed as Via Span), The DuPont Merck Pharmaceutical
Co (Wilmington, Del).
Results
Resting Force
After normalization, the arterial rings were set at 90% of the
diameter equivalent to 40 mm Hg. This passive transmural
pressure was 27.9  0.4 mm Hg (n  131), which is in
physiological range. With regard to the resting force, there
were no significant differences between the arteries exposed
to hyperkalemia, E-C, UW, and control (Krebs’) solution (P
 .5). Table 2 gives the details of the resting force in these
pulmonary microarteries.
U46619-Induced Contraction Force
In all porcine pulmonary microarterial rings, U46619 (7.5
log M) induced a rapidly developed and stable tension
(ranging from 2 to 3.5 mN), which was not significantly
different compared with the control in all groups.
Role of EDHF-Mediated Relaxation Induced by BK or
A23187
In control rings, BK or A23187 induced 97.1  2% (EC50
7.18  0.40 log M, n  8) or 73.7  7.6% (EC50 6.45
 0.43 log M, n  7) relaxation. With the presence of
INDO, L-NNA, and HbO, this relaxation (mediated by
EDHF) reduced to 69.6  6.3% (P  .003) with EC50 of
7.54  0.18 log M (P  .39) or 38.7  4.3% (P  .02)
with EC50 of 6.34  0.17 log M (P  .9) (Figure 1).
These experiments demonstrate that EDHF plays a role in
the pulmonary microarteries.
The effect of hyperkalemia. In group I, after exposure
to hyperkalemia, the EDHF-mediated relaxation was signif-
icantly reduced in either BK (group Ia: 38.6 3.0% vs 59.1
 7.4% in control; 95% CI: 3.8% to 37.2%; P  .02) or
A23187 (group Ib: 22.7 0.03% vs 36.6 0.02% in control;
P  .01) subgroup (Figure 2).
With regard to the EC50, the exposure to hyperkalemia
did not change the EC50 in either BK (group Ia: 7.41 
0.15 vs 7.52  0.12 log M, P .45) or A23187 (6.84 
0.37 vs 6.16  0.44 log M, P  .58) subgroup.
Effect of E-C solution on the EDHF-mediated relax-
ation. Similarly, in group II, after exposure to E-C solu-
tion, the EDHF-mediated relaxation was significantly re-
duced in either BK (group IIa: 51.9 8.4% vs 60.3 6.1%
in control; 95% CI, 1.1% to 15.7%, P  .02) or A23187
(group IIb: 12.5  0.02% vs 33.8  0.07% in control; 95%
CI: 0.05% to 0.37%, P  .02) subgroup (Figure 3).
With regard to the EC50, the exposure to E-C solution
did not change the EC50 in either BK (group IIa: 7.41 
0.23 vs 7.51  0.28 log M, P .62) or A23187 (group IIb:
6.22  0.46 vs 6.4  0.28 log M, P  .68) subgroup.
Effect of UW solution on the EDHF-mediated relax-
ation. Again, in group III, after exposure to UW solution,
the EDHF-mediated relaxation was significantly reduced in
either BK (group IIIa: 49.3  7.3 vs 65.2  3.5% in control;
95% CI, 0.4% to 31.4%; P 0.04) or A23187 (group IIIb: 13.2
 0.03% vs 31.0  0.05% in control; P  0.03, Figure 4)
subgroup.
With regard to the EC50, the exposure to E-C solution
did not change the EC50 in either BK (group IIIa: 7.69 
0.20 vs 7.34  0.20 log M, P .1) or A23187 (group IIIb:
7.32  0.88 vs 6.66  0.43 log M, P  .44) subgroup.
Effect of UW and E-C solution on the contractility of
the pulmonary microartery. Compared with Krebs’ solu-
tion, after incubation with E-C or UW solution for 4 hours,
the U46619 (10 to 6.5 log M)-induced maximal contrac-
tion was significantly decreased (group IVa: 1.5  0.3 vs
2.4  0.4, 95% CI: 0.2% to 1.5, P  .01; group IVb: 1.2 
0.2 vs 2.2  0.3 mN, 95% CI: 1.94 to 0.16, P  .02;
Figure 5). However, there were no changes with regard to
the EC50. After incubation with E-C solution, the EC50 was
7.53  0.36 log M, compared with control of 7.69 
0.16 log M (P  .2), whereas after incubation with UW
solution, the EC50 was 6.44  0.46 log M vs 6.95 
0.43 log M in control (P  .43).
TABLE 2. Resting force (mN) in porcine pulmonary microarteries
Group Bradykinin Control P 95% CI Group A23187 Control P 95% CI
Ia 1.1 1.1 .9 0.3-1.9 Ib 1.1 1.2 .2 0.4-0.1
IIa 1.0 1.0 .9 0.4-0.4 IIb 1.3 1.3 .8 0.2-0.2
IIIa 1.0 1.2 .2 0.1-0.3 IIIb 1.3 1.1 .1 0.5-0.1
Values are means SE. See “Methods” for the details of the groups. Two microarterial rings were taken from the same artery and allocated into the paired
groups. P value was from the paired t test.
Zou et al Cardiothoracic Transplantation
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 1 211
TX
Discussion
The present study has demonstrated that (1) EDHF-medi-
ated (INDO-, L-NNA-, and HbO- resistant) endothelium-
dependent relaxation exists in the porcine pulmonary mi-
croartery; (2) after exposure to hyperkalemia (K115
mmol/L), the major component in organ preservation solu-
tions, the relaxation is reduced; (3) the preservation of lungs
in hypothermic organ preservation solutions (E-C or UW
solution) for the clinically relevant period reduces the
EDHF-mediated relaxation; and (4) the storage may also
affect the contractility of the microartery.
EDHF-Mediated Endothelial Function Exists in the
Pulmonary Microcirculation
Unlike NO and PGI2, which have been well studied, the nature
of EDHF has not been finally identified, although most re-
cently the cytochrome P450-monooxygenase metabolites of
arachidonic acid have been suggested to be EDHF.15 EDHF
induces vascular smooth muscle relaxation via hyperpolariza-
tion of the smooth muscle cells, which involves potassium
(K) channels.6,9,12,15-17 However, all of the these EDRFs are
released in response to the increase of intracellular (cytosolic-
free) calcium concentration in the endothelial cell.6
There is evidence that NO and EDHF are two primary
mechanisms of endothelium-dependent relaxation.18 How-
ever, it is unclear whether EDHF plays a role in the pul-
monary microcirculation. We have previously demonstrated
that to study EDHF, it is essential to have all NO production
eliminated by not only NO synthesis inhibitors such as
L-NNA, but also NO scavenger HbO.12-14 Therefore, in the
present study, L-NNA and HbO were present in all experi-
ments to study EDHF. Under such circumstance, BK or
Figure 2. Mean concentration-relaxation (% of contraction by
U46619) curves for BK (n  8) or A23187 (n  7) in the presence of
7 mol/L INDO, 300 mol/L L-NNA, and 20 mol/L HbO after
exposure to hyperkalemia (K115 mmol/L) or Krebs’ solution
(control) at 37°C for 1 hour. Two artery rings were taken from the
same artery and allocated into the paired groups. Vertical error
bars are 1 SEM. *P < .05, paired t test.
Figure 3. Mean concentration-relaxation (% of contraction by
U46619) curves for BK (n  8) or A23187 (n  7) in the presence of
7 mol/L INDO, 300 mol/L L-NNA, and 20 mol/L HbO after
exposure to Euro-Collins (E-C) or Krebs’ solution (control) at 4°C
for 4 hours. Two artery rings were taken from the same artery and
allocated into the paired groups. Vertical error bars are 1 SEM. *P
< .05, paired t test.
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A23187 induced 69.6% or 38.7% relaxation. These two ago-
nists induce endothelium-dependent relaxation through dif-
ferent mechanisms. BK-induced release of endothelium-
derived relaxing factors is receptor-dependent as BK
stimulates B2 receptors on the endothelial cell to release a
number of relaxing factors.19-21 Additionally, BK induces
vasodilatation through a potassium channel–dependent
mechanism via endothelium.22 In contrast, A23187 is a cal-
cium ionophore that directly increases free Ca2 in the
endothelial cells and triggers the cascade of events in en-
dothelial cell activation, leading to the release of endothe-
lium-derived vasodilators.23 The fact that in the present
study both BK and A23187 induced a significant relaxation
when the production of NO and PGI2 were abolished suggests
the existence and the role of EDHF in the pulmonary micro-
vasculature.
Hyperkalemia Exposure Reduces EDHF-Related
Relaxation and Possible Mechanism
High potassium concentration is one of the major compo-
nents in either cardioplegia or organ preservation solution. It
has been repeatedly demonstrated that hyperkalemia may
affect the endothelial function. We have previously demon-
strated that hyperkalemia affects the coronary endothelial
function in either the large conductance3,6,9 or the micro-
(resistance) artery4 through the EDHF mechanism. This is
because hyperkalemia depolarizes the membrane potential
of the smooth muscle of the coronary artery that interacts
the hyperpolarization by EDHF. In the present study, we
have for the first time demonstrated that hyperkalemia also
affects the EDHF pathway in the pulmonary microarteries.
This shows that the effect of high potassium on the EDHF
mechanism is independent to the type of vessel. This phe-
Figure 4. Mean concentration-relaxation (% of contraction by
U46619) curves for BK (n  8) or A23187 (n  7) in the presence of
7 mol/L INDO, 300 mol/L L-NNA, and 20 mol/L HbO after
exposure to University of Wisconsin (UW) or Krebs’ solution
(control) at 4°C for 4 hours. Two artery rings were taken from the
same artery and allocated into the paired groups. Vertical error
bars are 1 SEM. *P < .05, paired t test.
Figure 5. Mean contraction force (mN) to U46619 (10 to 6.5 log
M) after incubation with Euro-Collins (E-C) (A) or University of
Wisconsin (UW) solution (B) and Krebs’ solution (Control) at 4°C
for 4 hours. Two artery rings were taken from the same artery and
allocated into the paired groups. *P < .05, n  8, respectively,
paired t test.
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nomenon has clinical importance as high potassium is con-
tained in many clinically used solutions, as mentioned pre-
viously.
The Effect of E-C and UW Solutions on the EDHF-
Mediated Relaxation in the Pulmonary Microarteries
E-C and UW solutions are of the intracellular type solutions
and are clinically used most frequently in lung transplanta-
tion, with E-C and UW being used in 77% and 25% of
centers.24 E-C and UW solutions are designed for cold
storage of the organs. Hypothermic flush perfusion is the
method most commonly used for pulmonary preservation in
clinical practice to limit ischemic injury to the lung, al-
though some studies have shown that lung preservation is
superior when a more moderate hypothermia with a tem-
perature of 10°C is used.25 However, because of the con-
cerns regarding the deleterious effects of flush and storage
temperatures greater than 10°C and the difficulties in main-
taining this temperature during the procurement procedure,
clinical flush perfusion continues to be performed at the
lower temperatures. In lung transplantation surgery, most
flush solutions are administered at 4°C so that metabolism is
slowed by nearly 80% to 90%. We therefore studied the effect
of the preservation with E-C and UW solutions at 4°C.
Further, preservation of the lung should involve both
parenchyma and vasculature of the lung. Preservation of
pulmonary endothelium has been looked at as a factor for
better lung preservation.26-28 However, although endotheli-
um-dependent relaxation in pulmonary arteries has been
studied,26-28 due to the complexity of the endothelial func-
tion, previous studies only looked at the function of endo-
thelium as a whole and there have been no reports on the
effect of preservation methods by using either E-C or UW
solution on the particular EDHF-mediated endothelial function.
As hyperkalemic solutions, the concentration of potas-
sium in the E-C is as high as 115 mmol/L, and in UW
solution, 125 mmol/L. As mentioned previously, such high
potassium concentrations may affect EDHF-mediated relax-
ation and this has been demonstrated in the coronary arter-
ies.3,4,6-8 However, the components in both E-C and UW
solutions are complex (see Table 1) and these components
in the solutions may interact each other. It is therefore
difficult to predict the final action of the solution on the
endothelial function. Moreover, the effect of either E-C or
UW solution in the pulmonary microarteries has not been
reported. The present study clearly demonstrates that the
EDHF-mediated relaxation induced by either BK or
A23187 is reduced after the cold storage with either E-C or
UW solution for a clinically relevant period (4 hours). This
fact should be taken into account in the clinical lung pres-
ervation for transplantation to overcome this shortage of the
preservation method.
Study Limitations
The present study is an in vitro experimental investigation.
In this model, the individual EDRFs may be accurately
separated and studied in microarteries. However, in vivo
animal or human studies may provide further insights on the
impairment of the EDHF-mediated function in the pulmo-
nary circulation.
Conclusions
In summary, the present study demonstrated that hypother-
mic storage with hyperkalemic organ preservation solutions
such as E-C or UW solutions impair a special pathway of
the endothelial function (ie, the EDHF-pathway in the pul-
monary microarteries). Because the microarteries are the
major resistance arteries in the pulmonary circulation, the
reduced EDHF-mediated relaxation in the microcirculation
after the storage may impair the flow capacity of the pul-
monary artery by increasing the pulmonary arterial resis-
tance during the reperfusion period. This may have adverse
effects in the clinical lung transplantation. The present study
therefore opens a new area of the lung preservation in
transplantation surgery. Better preservation methods should
be explored to further improve the results of lung transplan-
tation surgery.
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